Karen Mooney

Karen Mooney
Queen's University Belfast | QUB

MPharm PhD

About

15
Publications
2,492
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
461
Citations
Introduction

Publications

Publications (15)
Chapter
Delivery of active pharmaceutical ingredients through transdermal route has been limited due to the excellent barrier properties of the stratum corneum (SC) of the skin. Only drugs with very specific physicochemical properties (molecular weight < 500 daltons, adequate lipophilicity and low melting point) can be successfully administered transdermal...
Article
Full-text available
We describe, for the first time the use of hydrogel-forming microneedle (MN) arrays for minimally-invasive extraction and quantification of drug substances and glucose from skin in vitro and in vivo. MN prepared from aqueous blends of hydrolysed poly(methyl-vinylether-co-maleic anhydride) (11.1% w/w) and poly(ethyleneglycol) 10,000 daltons (5.6% w/...
Article
Background: Cystic Fibrosis (CF) management requires complex treatment regimens but adherence to treatment is poor and has negative health implications. There are various methods of measuring adherence, but little is known regarding the extent of adherence measurement in CF centres throughout the UK and Ireland. Objective: To determine the adher...
Article
Objectives Cystic Fibrosis (CF) management requires complex treatment regimens but adherence to treatment is poor. Various methods exist to measure adherence, but little is known about the extent of their use in CF centres. The aims of this work were to determine adherence monitoring practices in CF centres and to establish CF pharmacists’ views on...
Article
Development of formulations and drug delivery strategies for paediatric use is challenging, partially due to the age ranges within this population, resulting in varying requirements to achieve optimised patient outcomes. Although the oral route of drug delivery remains the preferred option, there are problematic issues, such as difficulty swallowin...
Article
Microneedle (MN) arrays could offer a pain-free, minimally invasive approach to monitoring. This is envisaged to be particularly beneficial for younger patients, but parents' views to date are unknown. The aim of this study was to explore parental perceptions of MN-mediated ISF monitoring, as an alternative to the use of conventional blood sampling...
Article
Full-text available
The Silences of the Archives, the Reknown of the Story. The Martin Guerre affair has been told many times since Jean de Coras and Guillaume Lesueur published their stories in 1561. It is in many ways a perfect intrigue with uncanny resemblance, persuasive deception and a surprizing end when the two Martin stood face to face, memory to memory, befor...
Article
We describe, for the first time, quantification of in-skin swelling and fluid uptake by hydrogel-forming microneedle (MN) arrays and skin barrier recovery in human volunteers. Such MN arrays, prepared from aqueous blends of hydrolyzed poly(methylvinylether/maleic anhydride) (15%, w/w) and the cross-linker poly(ethyleneglycol) 10,000 Da (7.5%, w/w),...
Article
The emerging field of microneedle-based minimally invasive patient monitoring and diagnosis is reviewed. Microneedle arrays consist of rows of micron-scale projections attached to a solid support. They have been widely investigated for transdermal drug and vaccine delivery applications since the late 1990s. However, researchers and clinicians have...
Article
To explore children's views on microneedle use for this population, particularly as an alternative approach to blood sampling, in monitoring applications, and so, examine the acceptability of this approach to children. Focus groups were conducted with children (aged 10-14 years) in a range of schools across Northern Ireland. Convenience sampling wa...
Chapter
Microneedles (MN) are micron-sized needles, ranging from 25 to 2000. μm in height, made of a variety of materials and shapes. Application of MNs to the skin can create micron-sized transport pathways that allow enhanced delivery of a wide range of drug molecules. The concept of MNs was first conceived in 1976; however, it was not possible to make t...

Network

Cited By